Open Access“Treat to Persist”, a deepening of the “Treat to Target”
Author(s) -
Gustavo Citera,
Eduardo Mysler,
Enrique R. Soriano
Publication year - 2020
Publication title -
revista argentina de reumatología
Language(s) - English
Resource type - Journals
eISSN - 2362-3675
pISSN - 0327-4411
DOI - 10.47196/rar.v31i2.401
Subject(s) - rheumatoid arthritis , medicine , life expectancy , quality of life (healthcare) , intensive care medicine , physical therapy , normalization (sociology) , disease , nursing , population , environmental health , sociology , anthropology
The treatment of rheumatoid arthritis (RA) has evolved considerably in recent years, resulting in a notable improvement in the functional capacity, quality and life expectancy of patients1. This improvement is not only due to the development of more and better medications, but mainly to the internalization by most rheumatologists of the concept of treat to target (T2T) or goal-directed treatment2. The T2T establishes 4 basic principles, which include: A) The treatment of rheumatoid arthritis must be based on a joint decision of the rheumatologist and the patient, B) The primary objective of the treatment of RA is to promote a good quality of life long-term, through the control of symptoms, prevention of structural damage, normalization of functional capacity and social participation of the patient, C) Suppression of inflammation is the main way to achieve these goals, D) Treatment towards a Objectively, evaluating disease activity and adjusting treatment accordingly, improves the outcome of RA patients.